Contrast agent, Magnetic resonance imaging, Microvascular permeability, Therapy, Tumor angiogenesis
dx.doi.org/10.1002/jmri.20184, hdl.handle.net/1765/61345
Journal of Magnetic Resonance Imaging
Department of Radiology

Preda, A, Novikov, V, Möglich, M, Turetschek, K, Shames, D.M, Brasch, R.C, … Roberts, T.P.L. (2004). MRI monitoring of Avastin™ antiangiogenesis therapy using B22956/1, a new blood pool contrast agent, in an experimental model of human cancer. Journal of Magnetic Resonance Imaging, 20(5), 865–873. doi:10.1002/jmri.20184